Chiasson JL, et al.: A STOP-NIDDM Group: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial. Lancet 2002; 359: 2072-2077.
Hanefeld M, et al.: Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J 2004; 25: 10-16.
Diabetes Prevention Program Research Group: Effects of withdrawal from metformin on the development of diabetes in the prevention program. Diabetes Care 2003; 26: 977-980.
Zhou G, et al.: Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001; 108: 1167-1174.